{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:45:56Z","timestamp":1792511156063,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016242","name":"Barnekreftforeningen","doi-asserted-by":"publisher","award":["PedHemaCAR, no. 240005"],"award-info":[{"award-number":["PedHemaCAR, no. 240005"]}],"id":[{"id":"10.13039\/501100016242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016242","name":"Barnekreftforeningen","doi-asserted-by":"publisher","award":["no. 230004 [PERCAP]"],"award-info":[{"award-number":["no. 230004 [PERCAP]"]}],"id":[{"id":"10.13039\/501100016242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016242","name":"Barnekreftforeningen","doi-asserted-by":"publisher","award":["no. 240005 [PERHEMA]"],"award-info":[{"award-number":["no. 240005 [PERHEMA]"]}],"id":[{"id":"10.13039\/501100016242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Western Norway Regional Health Authority","doi-asserted-by":"publisher","award":["MyCAR"],"award-info":[{"award-number":["MyCAR"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005632","name":"National Centre for Research and Development","doi-asserted-by":"publisher","award":["NOR\/POLNOR\/ALTERCAR\/0056\/2019"],"award-info":[{"award-number":["NOR\/POLNOR\/ALTERCAR\/0056\/2019"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["no. 351914"],"award-info":[{"award-number":["no. 351914"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["no. 326300"],"award-info":[{"award-number":["no. 326300"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["no. 337468"],"award-info":[{"award-number":["no. 337468"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["no. 351915"],"award-info":[{"award-number":["no. 351915"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["CellFit, no. 326811"],"award-info":[{"award-number":["CellFit, no. 326811"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MEC-ONC\/0491\/2021"],"award-info":[{"award-number":["PTDC\/MEC-ONC\/0491\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011755","name":"National Center for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005856","name":"NOVA University Lisbon NOVA School of Science & Technology","doi-asserted-by":"publisher","award":["2022.04678.CEECIND"],"award-info":[{"award-number":["2022.04678.CEECIND"]}],"id":[{"id":"10.13039\/501100005856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005856","name":"NOVA University Lisbon NOVA School of Science & Technology","doi-asserted-by":"publisher","award":["2022.00943.CEECIND"],"award-info":[{"award-number":["2022.00943.CEECIND"]}],"id":[{"id":"10.13039\/501100005856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","award":["IIDEA, no. 223171"],"award-info":[{"award-number":["IIDEA, no. 223171"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103108","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:50:53Z","timestamp":1791471053000},"page":"103108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reviving low-affinity glycan-targeting CAR with combinatorial design"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5073-1522","authenticated-orcid":false,"given":"Christopher","family":"Forcados","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"K\u00f6ksal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9222-3034","authenticated-orcid":false,"given":"Eveline","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela","family":"Abrantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique O.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Josefsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"de Montlaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5527-6462","authenticated-orcid":false,"given":"Henrik T.Z.","family":"Helles\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlend.B.","family":"Smeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June H.","family":"Myklebust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso A.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmet","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Gelebart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else Marit","family":"Inderberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5869-1746","authenticated-orcid":false,"given":"S\u00e9bastien","family":"W\u00e4lchli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103108_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103108_bib2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric Antigen Receptor\u2013Modified T Cells for Acute Lymphoid Leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103108_bib3","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103108_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2162-3619-1-36","article-title":"CD19: a biomarker for B cell development, lymphoma diagnosis and therapy","volume":"1","author":"Wang","year":"2012","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2026.103108_bib5","first-page":"456","article-title":"How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies","volume":"39","author":"Reagan","year":"2021","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.xcrm.2026.103108_bib6","series-title":"The EBMT\/EHA CAR-T Cell Handbook [Internet]","article-title":"Management of Hypogammaglobulinaemia and B-Cell Aplasia. 2022 Feb 7","author":"Topp","year":"2022"},{"key":"10.1016\/j.xcrm.2026.103108_bib7","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2025.039","article-title":"Toxicities Associated with CAR-T Cell Therapies","volume":"17","author":"Testa","year":"2025","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.xcrm.2026.103108_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2020.08.022","article-title":"Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies","volume":"183","author":"Parker","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103108_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2147\/JBM.S281247","article-title":"Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma","volume":"12","author":"Castaneda-Puglianini","year":"2021","journal-title":"J. Blood Med."},{"key":"10.1016\/j.xcrm.2026.103108_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-3083.1985.tb01422.x","article-title":"Characterization of Two Murine Monoclonal Antibodies Reactive with Human B Cells","volume":"21","author":"Smeland","year":"1985","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103108_bib11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0092-8674(92)90070-S","article-title":"The B lymphocyte surface antigen CD75 is not an \u03b1-2,6-sialyltransferase but is a carbohydrate antigen, the production of which requires the enzyme","volume":"68","author":"Munro","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103108_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","article-title":"Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?","volume":"36","author":"Mereiter","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103108_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188464","article-title":"Altered glycosylation in cancer: A promising target for biomarkers and therapeutics","volume":"1875","author":"Thomas","year":"2021","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103108_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/0008-5472.CAN-07-1340","article-title":"\u03b12-6\u2013Linked Sialic Acids on N-Glycans Modulate Carcinoma Differentiation In vivo","volume":"68","author":"Hedlund","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103108_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1083\/jcb.116.2.423","article-title":"The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase","volume":"116","author":"Bast","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.103108_bib16","first-page":"206","article-title":"Expression of the CDw75 (beta-galactoside alpha 2,6-sialyltransferase) antigen on normal blood cells and in B-cell chronic lymphocytic leukaemia","volume":"74","author":"Guy","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2026.103108_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.172.2.641","article-title":"The B cell antigen CD75 is a cell surface sialytransferase","volume":"172","author":"Stamenkovic","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.103108_bib18","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/1097-0142(19930901)72:5<1522::AID-CNCR2820720505>3.0.CO;2-F","article-title":"CDw75 Antigen expression in human gastric carcinoma and adjacent mucosa","volume":"72","author":"David","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2026.103108_bib19","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3748\/wjg.v10.i11.1682","article-title":"CDw75 is a significant histopathological marker for gastric carcinoma","volume":"10","author":"Shen","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.xcrm.2026.103108_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0344-0338(11)80325-0","article-title":"CDw75 Antigen Expression in Breast Lesions","volume":"189","author":"Reed","year":"1993","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.xcrm.2026.103108_bib21","first-page":"580","article-title":"Identification of proteins with the CDw75 epitope in human colorectal cancer","volume":"15","author":"Mari\u00f1o-Crespo","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.xcrm.2026.103108_bib22","first-page":"2470","article-title":"Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed\/refractory large B-cell lymphoma","volume":"141","author":"Roddie","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103108_bib23","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016234","article-title":"Combinatorial CAR design improves target restriction","volume":"296","author":"K\u00f6ksal","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.103108_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh1962","article-title":"Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence","volume":"13","author":"Katsarou","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103108_bib25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1349-7006.1988.tb01535.x","article-title":"Production of monoclonal antibodies directed against carbohydrate moieties of cell surface glycoproteins","volume":"79","author":"Fukui","year":"1988","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103108_bib26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1158\/2159-8290.CD-19-0945","article-title":"Tuning the Antigen Density Requirement for CAR T-cell Activity","volume":"10","author":"Majzner","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103108_bib27","first-page":"341","article-title":"Development and characterization of antibodies to carbohydrate antigens","volume":"534","author":"Heimburg-Molinaro","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.103108_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1039\/D1CB00019E","article-title":"Glycan\u2013protein interactions determine kinetics of N-glycan remodeling","volume":"2","author":"Mathew","year":"2021","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.xcrm.2026.103108_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/stemcells.19-6-556","article-title":"CD Antigens 2001: Aims and Results of HLDA Workshops","volume":"19","author":"Mason","year":"2001","journal-title":"Stem Cell."},{"key":"10.1016\/j.xcrm.2026.103108_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/glycob\/cwaa110","article-title":"Regulation of ST6GAL1 sialyltransferase expression in cancer cells","volume":"31","author":"Dorsett","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.xcrm.2026.103108_bib31","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/cells10051260","article-title":"Siglec Ligands","volume":"10","author":"Gonzalez-Gil","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.103108_bib32","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/2326-6066.CIR-22-0366","article-title":"Targeting the Siglec-Sialic Acid Immune Axis in Cancer: Current and Future Approaches","volume":"10","author":"L\u00e4ubli","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.103108_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/biom12060743","article-title":"Glycome Profiling of Cancer Cell Lines Cultivated in Physiological and Commercial Media","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.xcrm.2026.103108_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.427","article-title":"Functional roles of sialylation in breast cancer progression through miR-26a\/26b targeting ST8SIA4","volume":"7","author":"Ma","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.103108_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.962908","article-title":"ST6Gal1: Oncogenic signaling pathways and targets","volume":"9","author":"Gc","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.xcrm.2026.103108_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/antib9040053","article-title":"Structure, Function, and Therapeutic Use of IgM Antibodies","volume":"9","author":"Keyt","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.xcrm.2026.103108_bib37","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41590-026-02559-7","article-title":"Costimulation drives CAR-T cell division fate","volume":"27","author":"Adeshakin","year":"2026","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103108_bib38","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy","volume":"130","author":"Hay","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103108_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.xcrm.2026.103108_bib40","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/bloodadvances.2018029678","article-title":"Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma","volume":"3","author":"K\u00f6ksal","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2026.103108_bib41","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2003-05-1524","article-title":"Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region","volume":"102","author":"Heemskerk","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103108_bib42","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1038\/s41388-021-01801-w","article-title":"ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab","volume":"40","author":"Duarte","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.103108_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027930","article-title":"A practical approach to T-cell receptor cloning and expression","volume":"6","author":"W\u00e4lchli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.103108_bib44","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1128\/jvi.69.12.7430-7436.1995","article-title":"High-titer packaging cells producing recombinant retroviruses resistant to human serum","volume":"69","author":"Cosset","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.103108_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/bcmd.1998.0184","article-title":"An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene","volume":"24","author":"Persons","year":"1998","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.xcrm.2026.103108_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1472-6750-10-81","article-title":"Improved Tet-responsive promoters with minimized background expression","volume":"10","author":"Loew","year":"2010","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103108_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/glycob\/cwx101","article-title":"A validated gRNA library for CRISPR\/Cas9 targeting of the human glycosyltransferase genome","volume":"28","author":"Narimatsu","year":"2018","journal-title":"Glycobiology"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126005252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126005252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:05:37Z","timestamp":1792508737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126005252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666379126005252"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103108","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reviving low-affinity glycan-targeting CAR with combinatorial design","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103108"}}